Article

COA Releases 2018 Year in Review

The Community Oncology Alliance has released its 2018 Year in Review, offering a comprehensive look at highlights and successes from the year.

The Community Oncology Alliance has released its 2018 Year in Review, offering a comprehensive look at highlights and successes from the year. The Year in Review includes action taken on key legislation and public policy, leaders and conveners for community oncology, support for community oncology practices and professionals, and more. Highlights include actions taken against proposed cuts to reimbursement, negative effects of pharmacy benefit managers, and cancer clinic consolidation.

Read the full report here.

Related Videos
Douglas Flora, MD, FACCC
rachel rohaidy
Douglas Flora, MD, FACCC
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Rachel Rohaidy, MD
Andrew Kuykendall, MD, Moffitt Cancer Center
Dr Rebecca Haberman
Frederick L. Locke, MD
Screenshot of an interview with Shaun McKenzie, MD
Related Content
Air pollution | Image Credit: hramovnick - stock.adobe.com
March 10th 2025

Climate Change, Pollution’s Growing Impact on Dermatology

Brooke McCormick
Experts stressed the importance of dermatologists engaging in climate advocacy and adopting sustainable practices, as their actions may inspire others to follow suit.
Managed Care Cast Logo
February 4th 2025

Politics vs Science: The Future of US Public Health

Maggie L. Shaw Perry N. Halkitis, PhD, MS, MPH
On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Clinical trial enrollment | Image: FreePik
March 6th 2025

ACCC Research Highlights Quest to Boost Trial Enrollment, Address Disparities

Mary Caffrey
Posters presented at the Association of Cancer Care Centers (ACCC) opening session covered initiatives to boost clinical trial diversity and address disparities in bladder cancer trials.
Managed Care Cast
January 14th 2025

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

Giuliana Grossi
Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.
Apple and oranges | Image Credit: © vivekFx - stock.adobe.com
February 20th 2025

Contributor: Beyond a One-Size-Fits-All for Managed Care Plan Benchmarks

Jarrod McNaughton Edward Juhn, MD, MBA, MPH
Comparing plans with similar characteristics, such as size, geographic location, or demographics served, allows for more meaningful insights and improvement opportunities.
Regina Barragan-Carrillo, MD | Image: Photo provided by ASCO
February 16th 2025

“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”

Regina Barragan-Carrillo, MD Interview by Mary Caffrey
Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo